Clinical Trial Update: Longitudinal Imaging Biomarkers of Disease Progression in DLB [Phase 4]

View source ↗

Summary

This document provides an update on an ongoing Phase 4 trial investigating longitudinal imaging biomarkers to monitor disease progression in dementia with Lewy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies

Snippet

Sponsor: Kejal Kantarci | Conditions: Lewy Body Disease | Phase 4 | Status: ENROLLING_BY_INVITATION